المؤلفون: Wang L; Department of Radiation Oncology, Eye & ENT Hospital, Fudan University, 83 Fenyang Road, Shanghai 200031, China., Tang T; Department of Radiation Oncology, Eye & ENT Hospital, Fudan University, 83 Fenyang Road, Shanghai 200031, China., Wang J; Department of Radiation Oncology, Eye & ENT Hospital, Fudan University, 83 Fenyang Road, Shanghai 200031, China., Lin T; Department of Ophthalmology, Eye & ENT Hospital, Fudan University, 83 Fenyang Road, Shanghai 200031, China., Li Y; Department of Oncology, 920th Hospital of Joint Logistics Support Force, 212 Daguan Road, Kunming 650031, China. Electronic address: liyi3443@hotmail.com., Song X; Department of Radiation Oncology, Eye & ENT Hospital, Fudan University, 83 Fenyang Road, Shanghai 200031, China. Electronic address: muqinger@sina.com.

المصدر: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Jul; Vol. 196, pp. 110282. Date of Electronic Publication: 2024 Apr 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Choroid Neoplasms*/radiotherapy , Choroid Neoplasms*/pathology , Hemangioma*/radiotherapy , Radiotherapy, Intensity-Modulated*/methods , Radiotherapy, Intensity-Modulated*/adverse effects , Radiotherapy Dosage* , Visual Acuity*/radiation effects, Humans ; Male ; Female ; Middle Aged ; Adult ; Retrospective Studies ; Aged ; Adolescent ; Treatment Outcome ; Young Adult

المؤلفون: Ohguri T; Department of Therapeutic Radiology, University Hospital of Occupational and Environmental Health, Kitakyushu, Japan ogurieye@med.uoeh-u.ac.jp., Morisaki T; Department of Therapeutic Radiology, University Hospital of Occupational and Environmental Health, Kitakyushu, Japan., Itamura H; Department of Therapeutic Radiology, University Hospital of Occupational and Environmental Health, Kitakyushu, Japan., Tani S; Department of Therapeutic Radiology, University Hospital of Occupational and Environmental Health, Kitakyushu, Japan., Yatera K; Department of Respiratory Medicine, University Hospital of Occupational and Environmental Health, Kitakyushu, Japan., Tanaka F; Second Department of Surgery, University Hospital of Occupational and Environmental Health, Kitakyushu, Japan.

المصدر: Anticancer research [Anticancer Res] 2024 Jul; Vol. 44 (7), pp. 2989-2995.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Clarithromycin*/therapeutic use , Radiation Pneumonitis*/prevention & control , Radiation Pneumonitis*/etiology , Lung Neoplasms*/radiotherapy , Lung Neoplasms*/pathology , Radiotherapy, Intensity-Modulated*/adverse effects , Radiotherapy, Intensity-Modulated*/methods, Humans ; Male ; Female ; Aged ; Middle Aged ; Retrospective Studies ; Aged, 80 and over ; Adult

المؤلفون: Li Y; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, China.; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Shanghai, China., Guan X; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, China.; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, China., Xing X; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, China.; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Shanghai, China., Hu C; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, China.; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Shanghai, China.

المصدر: Head & neck [Head Neck] 2024 Jul; Vol. 46 (7), pp. 1766-1776. Date of Electronic Publication: 2024 Apr 09.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: John Wiley And Sons Country of Publication: United States NLM ID: 8902541 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0347 (Electronic) Linking ISSN: 10433074 NLM ISO Abbreviation: Head Neck Subsets: MEDLINE

مواضيع طبية MeSH: Radiotherapy, Intensity-Modulated*/adverse effects , Radiotherapy, Intensity-Modulated*/methods , Propensity Score* , Nasopharyngeal Neoplasms*/radiotherapy , Nasopharyngeal Neoplasms*/mortality , Nasopharyngeal Neoplasms*/pathology , Nasopharyngeal Carcinoma*/radiotherapy , Nasopharyngeal Carcinoma*/mortality , Nasopharyngeal Carcinoma*/pathology , Heavy Ion Radiotherapy*/adverse effects , Heavy Ion Radiotherapy*/methods, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Adult ; Aged ; Treatment Outcome ; Kaplan-Meier Estimate ; Disease-Free Survival

المؤلفون: Bao YQ; Department of Radiation Oncology, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Cancer Institute, Nanchang, 330029, Jiangxi, China.; Medical Oncology, Nanchang People's Hospital, Nanchang People's Hospital Affiliated of Nanchang Medical College, Nanchang, 330009, Jiangxi, China., Yu TH; Department of Radiation Oncology, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Cancer Institute, Nanchang, 330029, Jiangxi, China., Huang W; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China., Mao QF; Department of Radiation Oncology, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Cancer Institute, Nanchang, 330029, Jiangxi, China., Tu GJ; Department of Radiation Oncology, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Cancer Institute, Nanchang, 330029, Jiangxi, China., Li B; Department of Radiation Oncology, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Cancer Institute, Nanchang, 330029, Jiangxi, China., Yi A; Department of Radiation Oncology, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Cancer Institute, Nanchang, 330029, Jiangxi, China., Li JG; Department of Radiation Oncology, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Cancer Institute, Nanchang, 330029, Jiangxi, China., Rao J; Department of Radiation Oncology, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Cancer Institute, Nanchang, 330029, Jiangxi, China. raojun1986@126.com., Zhang HW; Department of Radiation Oncology, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Cancer Institute, Nanchang, 330029, Jiangxi, China. 1761580890@qq.com., Jiang CL; Department of Radiation Oncology, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Cancer Institute, Nanchang, 330029, Jiangxi, China. jclil2002@163.com.; Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma, Medical College of Nanchang University, Nanchang, 330029, Jiangxi, China. jclil2002@163.com.

المصدر: Breast cancer (Tokyo, Japan) [Breast Cancer] 2024 Jul; Vol. 31 (4), pp. 726-734. Date of Electronic Publication: 2024 May 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Maruzen Co Country of Publication: Japan NLM ID: 100888201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-4233 (Electronic) Linking ISSN: 13406868 NLM ISO Abbreviation: Breast Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/radiotherapy , Breast Neoplasms*/pathology , Breast Neoplasms*/surgery , Breast Neoplasms*/mortality , Mastectomy, Segmental* , Radiotherapy, Intensity-Modulated*/adverse effects , Radiotherapy, Intensity-Modulated*/methods, Humans ; Female ; Middle Aged ; Retrospective Studies ; Aged ; Adult ; Radiotherapy, Adjuvant/methods ; Radiotherapy, Adjuvant/adverse effects ; Treatment Outcome ; Neoplasm Recurrence, Local ; Follow-Up Studies

المؤلفون: Knorren ER; Department of Obstetrics and Gynecology, Isala Hospital, Dokter van Deenweg 2, 8025AB Zwolle, The Netherlands; Department of Radiology, Isala Hospital, Dokter van Deenweg 2, 8025AB Zwolle, The Netherlands. Electronic address: e.r.knorren@isala.nl., de Ridder LA; Department of Obstetrics and Gynecology, Isala Hospital, Dokter van Deenweg 2, 8025AB Zwolle, The Netherlands., Nijholt IM; Department of Radiology, Isala Hospital, Dokter van Deenweg 2, 8025AB Zwolle, The Netherlands., Dijkstra JR; Department of Obstetrics and Gynecology, Isala Hospital, Dokter van Deenweg 2, 8025AB Zwolle, The Netherlands., Braat MNGJA; Department of Radiology, University Medical Center Utrecht, Heidelberglaan 100, 3584XC Utrecht, The Netherlands., Huirne JAF; Department of Obstetrics and Gynecology, Amsterdam University Medical Centre, location VUmc, Amsterdam Research Institute, Reproduction and Development, De Boelelaan 1117, 1081HV Amsterdam, The Netherlands., Boomsma MF; Department of Radiology, Isala Hospital, Dokter van Deenweg 2, 8025AB Zwolle, The Netherlands; Imaging & Oncology Division, Image Sciences Institute, University Medical Center Utrecht, Heidelberglaan 100, 3584XC Utrecht, The Netherlands., Schutte JM; Department of Obstetrics and Gynecology, Isala Hospital, Dokter van Deenweg 2, 8025AB Zwolle, The Netherlands.

المصدر: European journal of obstetrics, gynecology, and reproductive biology [Eur J Obstet Gynecol Reprod Biol] 2024 Jun; Vol. 297, pp. 15-23. Date of Electronic Publication: 2024 Mar 26.

نوع المنشور: Systematic Review; Journal Article; Review

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 0375672 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7654 (Electronic) Linking ISSN: 03012115 NLM ISO Abbreviation: Eur J Obstet Gynecol Reprod Biol Subsets: MEDLINE

مواضيع طبية MeSH: Endometriosis*/surgery , Endometriosis*/therapy , Abdominal Wall*/surgery , High-Intensity Focused Ultrasound Ablation*/adverse effects , High-Intensity Focused Ultrasound Ablation*/methods, Humans ; Female ; Treatment Outcome ; Ultrasonography, Interventional

المؤلفون: Iocolano M; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Yegya-Raman N; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Friedes C; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Wang X; Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Kegelman T; Department of Radiation Oncology, Delaware Radiation Oncology Associates, Christiana Care Health Systems, Newark, Delaware, USA., Lee SH; Department of Radiation Oncology, Division of Physics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Duan L; Department of Radiation Oncology, Division of Physics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Li B; Department of Radiation Oncology, Division of Physics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Levin WP; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Cengel KA; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Konski A; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Langer CJ; Division of Hematology/Oncology University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Cohen RB; Division of Hematology/Oncology University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Sun L; Division of Hematology/Oncology University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Aggarwal C; Division of Hematology/Oncology University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Doucette A; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Xiao Y; Department of Radiation Oncology, Division of Physics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Kevin Teo BK; Department of Radiation Oncology, Division of Physics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., O'Reilly S; Department of Radiation Oncology, Division of Physics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Zou W; Department of Radiation Oncology, Division of Physics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Bradley JD; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Simone CB 2nd; New York Proton Center, New York, New York, USA., Feigenberg SJ; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

المصدر: Cancer [Cancer] 2024 Jun 01; Vol. 130 (11), pp. 2031-2041. Date of Electronic Publication: 2024 Jan 31.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/radiotherapy , Carcinoma, Non-Small-Cell Lung*/therapy , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/drug therapy , Radiotherapy, Intensity-Modulated*/methods , Radiotherapy, Intensity-Modulated*/adverse effects , Lung Neoplasms*/pathology , Lung Neoplasms*/therapy , Lung Neoplasms*/radiotherapy , Lung Neoplasms*/drug therapy , Lung Neoplasms*/mortality , Hospitalization*/statistics & numerical data , Proton Therapy*/methods , Proton Therapy*/adverse effects , Chemoradiotherapy*/methods , Chemoradiotherapy*/adverse effects, Humans ; Female ; Male ; Aged ; Middle Aged ; Retrospective Studies ; Immune Checkpoint Inhibitors/therapeutic use ; Immune Checkpoint Inhibitors/adverse effects ; Lymphopenia/etiology ; Antibodies, Monoclonal

المؤلفون: Jiang T; Department of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao, 266700, China., Tian J; Department of Medicine, Qingdao University, Qingdao, 266700, China., Lei P; Department of Medicine, Qingdao University, Qingdao, 266700, China., Meng C; Department of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao, 266700, China., Fu J; Department of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao, 266700, China., Cao L; Department of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao, 266700, China., Cheng J; Department of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao, 266700, China., Zhou F; Department of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao, 266700, China., Zhang H; Department of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao, 266700, China., Song H; Department of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao, 266700, China., Lu H; Department of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao, 266700, China. Lhj82920608@163.com., Wei X; Department of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao, 266700, China. weixjjn@163.com.

المصدر: Radiation oncology (London, England) [Radiat Oncol] 2024 May 28; Vol. 19 (1), pp. 64. Date of Electronic Publication: 2024 May 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101265111 Publication Model: Electronic Cited Medium: Internet ISSN: 1748-717X (Electronic) Linking ISSN: 1748717X NLM ISO Abbreviation: Radiat Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Radiotherapy, Intensity-Modulated*/adverse effects , Radiotherapy, Intensity-Modulated*/methods , Breast Neoplasms*/radiotherapy , Breast Neoplasms*/surgery , Breast Neoplasms*/pathology , Mastectomy*, Humans ; Female ; Retrospective Studies ; Middle Aged ; China/epidemiology ; Adult ; Neoplasm Recurrence, Local/pathology ; Aged

المؤلفون: Manfrida S; Department of Diagnostic Imaging, Radiation Oncology and Haematology, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy., Fionda B; Department of Diagnostic Imaging, Radiation Oncology and Haematology, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy., Mariani S; Department of Diagnostic Imaging, Radiation Oncology and Haematology, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy; silvia.mariani28@gmail.com., Luca V; Department of Diagnostic Imaging, Radiation Oncology and Haematology, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy., Bertolini R; Department of Diagnostic Imaging, Radiation Oncology and Haematology, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy., Barbaro B; Department of Diagnostic Imaging, Radiation Oncology and Haematology, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy., Chiloiro G; Department of Diagnostic Imaging, Radiation Oncology and Haematology, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy., Frascino V; Department of Diagnostic Imaging, Radiation Oncology and Haematology, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy., Tagliaferri L; Department of Diagnostic Imaging, Radiation Oncology and Haematology, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy., Gambacorta MA; Department of Diagnostic Imaging, Radiation Oncology and Haematology, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.; Catholic University of Sacred Heart, Rome, Italy.

المصدر: In vivo (Athens, Greece) [In Vivo] 2024 May-Jun; Vol. 38 (3), pp. 1306-1315.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8806809 Publication Model: Print Cited Medium: Internet ISSN: 1791-7549 (Electronic) Linking ISSN: 0258851X NLM ISO Abbreviation: In Vivo Subsets: MEDLINE

مواضيع طبية MeSH: Anus Neoplasms*/radiotherapy , Anus Neoplasms*/pathology , Anus Neoplasms*/mortality , Radiotherapy, Intensity-Modulated*/methods , Radiotherapy, Intensity-Modulated*/adverse effects , Radiotherapy Dosage*, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Treatment Outcome ; Aged, 80 and over ; Neoplasm Staging ; Retrospective Studies ; Anal Canal/pathology ; Carcinoma, Squamous Cell/radiotherapy ; Carcinoma, Squamous Cell/pathology ; Carcinoma, Squamous Cell/mortality

المؤلفون: Silveira SL; Department of Kinesiology, Health Promotion, and Recreation, University of North Texas, 1155 Union Circle #310769, Denton, TX 76203, USA; Department of Management, Policy, and Community Health, University of Texas Health Science Center at Houston, 1200 Pressler Street, Houston, TX, 77030, USA. Electronic address: stephanie.l.silveira@uth.tmc.edu., Motl RW; Department of Kinesiology and Nutrition, University of Illinois Chicago, 1919 W. Taylor St., 506H AHSB Chicago, IL, 60612, USA., Elmer DJ; Department of Kinesiology, Berry College, 2277 Martha Berry Hwy NW, Mount Berry, GA 30149, USA., Botkin T; Department of Kinesiology, Health Promotion, and Recreation, University of North Texas, 1155 Union Circle #310769, Denton, TX 76203, USA., Ontiveros T; Department of Kinesiology, Health Promotion, and Recreation, University of North Texas, 1155 Union Circle #310769, Denton, TX 76203, USA., Williams S; Department of Kinesiology, Health Promotion, and Recreation, University of North Texas, 1155 Union Circle #310769, Denton, TX 76203, USA., Hubbard EA; Department of Kinesiology, Health Promotion, and Recreation, University of North Texas, 1155 Union Circle #310769, Denton, TX 76203, USA; Department of Kinesiology, Berry College, 2277 Martha Berry Hwy NW, Mount Berry, GA 30149, USA.

المصدر: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Jul; Vol. 87, pp. 105695. Date of Electronic Publication: 2024 May 24.

نوع المنشور: Journal Article; Clinical Trial

بيانات الدورية: Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE

مواضيع طبية MeSH: Feasibility Studies* , High-Intensity Interval Training*/methods , Walking*/physiology , Multiple Sclerosis*/rehabilitation , Multiple Sclerosis*/therapy , Multiple Sclerosis*/physiopathology, Humans ; Female ; Male ; Adult ; Middle Aged ; Fatigue/therapy ; Fatigue/etiology ; Fatigue/rehabilitation ; Depression/therapy ; Treatment Outcome

المؤلفون: Layer JP; Department of Radiation Oncology, University Hospital Bonn/Venusberg-Campus 1, 53127, Bonn, Germany. julian.layer@ukbonn.de.; Institute of Experimental Oncology, University Hospital Bonn, Bonn, Germany. julian.layer@ukbonn.de., Fischer P; Department of Thoracic Surgery, St. Hildegardis Hospital, Augustinerinnen Krankenhäuser gGmbH, Cologne, Germany., Dejonckheere CS; Department of Radiation Oncology, University Hospital Bonn/Venusberg-Campus 1, 53127, Bonn, Germany., Sarria GR; Department of Radiation Oncology, University Hospital Bonn/Venusberg-Campus 1, 53127, Bonn, Germany., Mispelbaum R; Department of Oncology, Hematology, Rheumatology and Immune-Oncology, University Hospital Bonn, Bonn, Germany., Hattenhauer T; Department of Oncology, Hematology, Rheumatology and Immune-Oncology, University Hospital Bonn, Bonn, Germany., Wiegreffe S; Department of Radiation Oncology, University Hospital Bonn/Venusberg-Campus 1, 53127, Bonn, Germany., Glasmacher AR; Department of Radiation Oncology, University Hospital Bonn/Venusberg-Campus 1, 53127, Bonn, Germany., Layer K; Department of Radiation Oncology, University Hospital Bonn/Venusberg-Campus 1, 53127, Bonn, Germany., Nour Y; Department of Radiation Oncology, University Hospital Bonn/Venusberg-Campus 1, 53127, Bonn, Germany., Caglayan L; Department of Radiation Oncology, University Hospital Bonn/Venusberg-Campus 1, 53127, Bonn, Germany., Grau F; Department of Radiation Oncology, University Hospital Bonn/Venusberg-Campus 1, 53127, Bonn, Germany., Müdder T; Department of Radiation Oncology, University Hospital Bonn/Venusberg-Campus 1, 53127, Bonn, Germany., Köksal M; Department of Radiation Oncology, University Hospital Bonn/Venusberg-Campus 1, 53127, Bonn, Germany., Scafa D; Department of Radiation Oncology, University Hospital Bonn/Venusberg-Campus 1, 53127, Bonn, Germany., Giordano FA; Department of Radiation Oncology, University Medical Center Mannheim, Mannheim, Germany.; DKFZ-Hector Cancer Institute of the University Medical Center Mannheim, Mannheim, Germany., Lopez-Pastorini A; Department of Thoracic Surgery, St. Hildegardis Hospital, Augustinerinnen Krankenhäuser gGmbH, Cologne, Germany., Stoelben E; Department of Thoracic Surgery, St. Hildegardis Hospital, Augustinerinnen Krankenhäuser gGmbH, Cologne, Germany., Schmeel LC; Department of Radiation Oncology, University Hospital Bonn/Venusberg-Campus 1, 53127, Bonn, Germany., Leitzen C; Department of Radiation Oncology, University Hospital Bonn/Venusberg-Campus 1, 53127, Bonn, Germany.

المصدر: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] [Strahlenther Onkol] 2024 Jul; Vol. 200 (7), pp. 605-613. Date of Electronic Publication: 2023 Nov 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Urban & Vogel Country of Publication: Germany NLM ID: 8603469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-099X (Electronic) Linking ISSN: 01797158 NLM ISO Abbreviation: Strahlenther Onkol Subsets: MEDLINE

مواضيع طبية MeSH: Radiotherapy, Intensity-Modulated*/methods , Pleural Neoplasms*/radiotherapy , Pleural Neoplasms*/surgery , Pleural Neoplasms*/mortality , Organ Sparing Treatments*/methods , Mesothelioma, Malignant*/radiotherapy , Mesothelioma, Malignant*/surgery, Humans ; Male ; Female ; Aged ; Middle Aged ; Retrospective Studies ; Combined Modality Therapy ; Lung Neoplasms/radiotherapy ; Lung Neoplasms/surgery ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Mesothelioma/radiotherapy ; Mesothelioma/surgery ; Mesothelioma/mortality ; Aged, 80 and over ; Treatment Outcome ; Adult ; Pneumonectomy ; Chemotherapy, Adjuvant ; Neoplasm Staging ; Progression-Free Survival